Prolonged follow-up after initial therapy with 2-chlorodeoxyadenosine in patients with indolent non-Hodgkin lymphoma: results of Cancer and Leukemia Group B Study 9153.
      Google Scholar   
Citation:
Cancer vol 107 (12) 2817-25
Year:
2006
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Long-Term-Followup
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
Received
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Lymphoma
Sec. Committees:
   
Pharmas:
 
Grants:
CA02599, CA03927, CA04326, CA04457, CA07968, CA08025, CA11789, CA12046, CA16450, CA26806, CA31946, CA31983, CA33601, CA35279, CA41287, CA47555, CA47559, CA47577, CA47642, CA77597, CA77658  
Corr. Author:
 
Authors:
                 
Networks:
 
Study
CALGB-9153
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
Adolescent, Adult, Antineoplastic Agents, Cladribine, Female, Follow-Up Studies, Humans, Lymphoma, Non-Hodgkin, Male, Middle Aged, Neoplasm Staging, Treatment Outcome